Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Eli Lilly, Novartis sales and marketing update

July 11, 2016 7:00 AM UTC

Harvard Pilgrim Health Care Inc. (Boston, Mass.) will reimburse Lilly’s Trulicity dulaglutide to treat diabetes. The amount hinges on how well the drug lowers HbA1c relative to others in its class. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article